Key statistics

GlaxoSmithKline PLC (GSK:LSE) set a new 52-week high during today's trading session when it reached 1,714. Over this period, the share price is up 23.43%.
52-week range
Today
1,210.27Sep 29 20151,714Jul 27 2016
Markit short selling activity
Low
Med
High
Open1,675.5
High1,714
Low1,658.5
Bid1,690
Offer1,700
Previous close1,667
Average volume8.27m
Shares outstanding4.87bn
Free float4.83bn
P/E (TTM)132.98
Market cap81.22bn GBP
EPS (TTM)0.1254 GBP
Annual div (IAD)80.00 GBX
Annual div yield (IAD)4.80%
Div ex-dateMay 12 2016
Div pay-dateJul 14 2016
Data delayed at least 15 minutes, as of Jul 27 2016 17:09 BST.
More ▼

Investors Chronicle View

The last IC recommendation on GlaxoSmithKline PLC shares was Hold at 1,669 on 27 Jul 2016Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.